Genetic sequencing project receives more than $8 million in funding

McGill Faculty of Medicine news - mar, 03/18/2025 - 10:55
NeuRo Genomics Initiative will help better understand rare and aging-related neurological disorders affecting Canadians

 

A project led by Ziv Gan-Or, MD, PhD, at The Neuro (Montreal Neurological Institute-Hospital) of McGill University and Martine Tétreault, PhD, at Université de Montréal has received more than $8 million to sequence the genomes of 8,700 people, to map the role of genetics in neurological disorders.

Catégories: Global Health Feed

Genetic sequencing project receives more than $8 million in funding

McGill Faculty of Medicine news - mar, 03/18/2025 - 10:55
NeuRo Genomics Initiative will help better understand rare and aging-related neurological disorders affecting Canadians

 

A project led by Ziv Gan-Or, MD, PhD, at The Neuro (Montreal Neurological Institute-Hospital) of McGill University and Martine Tétreault, PhD, at Université de Montréal has received more than $8 million to sequence the genomes of 8,700 people, to map the role of genetics in neurological disorders.

Catégories: Global Health Feed

Genetic sequencing project receives more than $8 million in funding

McGill Faculty of Medicine news - mar, 03/18/2025 - 10:55
NeuRo Genomics Initiative will help better understand rare and aging-related neurological disorders affecting Canadians

 

A project led by Ziv Gan-Or, MD, PhD, at The Neuro (Montreal Neurological Institute-Hospital) of McGill University and Martine Tétreault, PhD, at Université de Montréal has received more than $8 million to sequence the genomes of 8,700 people, to map the role of genetics in neurological disorders.

Catégories: Global Health Feed

Global Health NOW: Tedros Details Human Costs of U.S. Cuts; Moving Beyond Stigma in Mexico; and The Bureaucrat Bridging Gaps

Global Health Now - mar, 03/18/2025 - 09:33
96 Global Health NOW: Tedros Details Human Costs of U.S. Cuts; Moving Beyond Stigma in Mexico; and The Bureaucrat Bridging Gaps View this email in your browser March 18, 2025 Forward Share Post A woman and her child attend a medical consultation at a mobile clinic operated in partnership with USAID. Port-au-Prince, Haiti, November 29, 2024. Clarens Siffroy SIFFROY/AFP via Getty Tedros Details Human Costs of U.S. Cuts  
WHO Director-General Tedros Adhanom Ghebreyesus had a request yesterday for the U.S.: reconsider its cancellation of global health support or withdraw the funds slowly giving countries time to prepare, STAT reports.
  • “The U.S. administration [is] within its rights to decide what it supports and to what extent,” Tedros said at a news conference. “But the U.S. also has a responsibility to ensure that if it withdraws direct funding for countries, it’s done in an orderly and humane way that allows them to find alternative sources of funding.”
Impact of U.S. cuts:
  • Malaria: An additional 15 million cases and 100,000+ deaths are possible this year because of stockouts or supply chain problems with malaria diagnostics, medications, and insecticide-treated bed nets.

  • HIV: Eight countries are experiencing “substantial disruptions” to antiretroviral supplies and will run out of medicines within months, Health Policy Watch reports.

  • TB: 27 countries in Africa and Asia are dealing with disruptions to diagnosis and treatment as well as “collapsing” surveillance systems, Tedros said.
Don’t ask Bill: Philanthropist Bill Gates has been lobbying the U.S. administration to continue funding vital global health programs and warned that no foundation could fill in the gap left by U.S. funding cuts, Reuters reports.

Related:
 
UK aid cuts will undermine global health and pose a risk to children's lives – The BMJ
 
Eighty percent of WHO-supported facilities in Afghanistan risk shutdown by June – WHO GLOBAL HEALTH VOICES The Latest One-Liners   The U.S. reported its first outbreak of H7N9 bird flu since 2017, on a farm of 47,654 commercial broiler breeder chickens in Noxubee, Mississippi; H7N9 has a higher death rate—killing 40% of people infected since 2013—than the H5N1 strain that killed one person in the U.S. earlier this year. CBC

A midwife and one of her employees were arrested and charged with performing illegal abortions at a health clinic near Houston; they are the first to be criminally charged under the state’s strict abortion ban. The Texas Tribune

Gender-affirming hormone therapy was associated with lower rates of moderate-to-severe depressive symptoms among 3,592 trans and nonbinary people prescribed the treatment compared to those who didn’t receive the treatment, finds a study spanning 48 months of follow-up. JAMA Network Open
 
The Trump administration removed a 2024 surgeon general's advisory on the public health impacts of gun violence and a related webpage from the Health and Human Services website (still available here); guns are the leading cause of death for children and teens in the U.S. Axios More Trump Administration News ____________________________________________________________As bird flu continues to spread, Trump administration sidelines key pandemic preparedness office – CNN

Trump administration cuts funding to long-term diabetes study: Report – The Independent

Scientists Say NIH Officials Told Them To Scrub mRNA References on Grants – Cancer Health

The VA will deny gender dysphoria treatment to new patients – NPR

Trump Administration Aims to Eliminate E.P.A.’s Scientific Research Arm – The New York Times (gift article)

Overseas universities see opportunity in U.S. ‘brain drain’ – Science DATA POINT HARM REDUCTION Moving Beyond Stigma in Mexico
For years, Mexico has taken a “prohibitionist, hardline approach” to drug use, reinforcing a stigma that ties drug use to other criminal activities.

But recently, health advocates have been taking a different tack—toward harm reduction.
  • One example: Checa tu Sustanciae (Check Your Substance) provides a way for people at events like music festivals to test drugs for fentanyl and other adulterants, and also equips those people with naloxone and practical information. 
The Quote: “The best way to reduce your risks is not to consume at all. But if you have made the decision to consume, we want you to have as much information as possible so you can take care of yourself,” said Zara Snapp, director of drug policy advocacy organization Instituto RIA.

AP GLOBAL HEALTH VOICES DISEASE DETECTIVES The Bureaucrat Bridging Gaps
Consider this maddening prospect: A 5-year-old girl in Texas is diagnosed with a rare brain-eating amoeba—and none of her doctors know the cure.

Meanwhile, in California, researchers had recently discovered an effective antibiotic remedy. But that paper never reached the doctors in Texas. 

This tragic disconnect all too frequently leads to preventable suffering and death. But in a must-read narrative, Michael Lewis examines the mission of an FDA worker “buried under six layers on an agency organizational chart” who is seeking to solve the problem by creating a database for rare diseases and treatments, called CURE ID.

Despite the database’s lifesaving potential, the question remains: Will anyone use it? 

The Washington Post (gift link)  RESOURCES QUICK HITS Afghanistan: Security Council renews UN mission as WHO warns of health catastrophe – UN News

Mexican president pledges stronger missing persons efforts after mass grave found – Reuters

With measles on the rise, two-dose vaccine strategy is 'more important than ever' Northwestern Now – Northwestern University (news release)

Injectable PrEP use leads to zero new HIV infections among gay, trans and non-binary Brazilians – aidsmap

The Silent Struggle: MamaCare360 Pushes to Prioritize Maternal Mental Health in Nigeria – Global Citizen

Nearly 50 million people sign up call for clean air action for better health – WHO

Why We Don’t Want to Talk About the COVID-19 Pandemic – Georgetown University

An Old Drug With A Hidden Talent – Bloomberg Issue No. 2692
Global Health NOW is an initiative of Johns Hopkins Bloomberg School of Public Health.

Contributors include Brian W. Simpson, MPH, Dayna Kerecman Myers, Annalies Winny, Morgan Coulson, Kate Belz, Melissa Hartman, Jackie Powder, and Rin Swann. Write us: dkerecm1@jhu.edu, like us on Facebook and follow us on Instagram @globalhealth.now and X @GHN_News.

Please send the Global Health NOW free sign-up link to friends and colleagues: http://www.globalhealthnow.org/subscribe

Want to change how you receive these emails? You can update your preferences or unsubscribe from this list. -->
ABOUT
SUPPORT US
NEWSLETTER ARCHIVE
  CONTACT US
  Copyright 2025 Johns Hopkins Bloomberg School of Public Health. All Rights Reserved. Views and opinions expressed in Global Health NOW do not necessarily reflect those of the Johns Hopkins Bloomberg School of Public Health or Johns Hopkins University.


Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.
Catégories: Global Health Feed

Scaringi Lecture Series in Speech Language Pathology - Research Talk

McGill Faculty of Medicine news - lun, 03/17/2025 - 14:53

Research Talk
Thursday April 3, 2025, 4:30 to 6:00 pm
2001 McGill College Ave. Room 606

Catégories: Global Health Feed

Scaringi Lecture Series in Speech Language Pathology - Research Talk

McGill Faculty of Medicine news - lun, 03/17/2025 - 14:53

Research Talk
Thursday April 3, 2025, 4:30 to 6:00 pm
2001 McGill College Ave. Room 606

Catégories: Global Health Feed

Scaringi Lecture Series in Speech Language Pathology - Research Talk

McGill Faculty of Medicine news - lun, 03/17/2025 - 14:53

Research Talk
Thursday April 3, 2025, 4:30 to 6:00 pm
2001 McGill College Ave. Room 606

Catégories: Global Health Feed

Scaringi Lecture Series in Speech Language Pathology - Research Talk

McGill Faculty of Medicine news - lun, 03/17/2025 - 14:53

Research Talk
Thursday April 3, 2025, 4:30 to 6:00 pm
2001 McGill College Ave. Room 606

Catégories: Global Health Feed

Scaringi Lecture Series in Speech Language Pathology - Research Talk

McGill Faculty of Medicine news - lun, 03/17/2025 - 14:53

Research Talk
Thursday April 3, 2025, 4:30 to 6:00 pm
2001 McGill College Ave. Room 606

Catégories: Global Health Feed

Scaringi Lecture Series in Speech Language Pathology - Research Talk

McGill Faculty of Medicine news - lun, 03/17/2025 - 14:53

Research Talk
Thursday April 3, 2025, 4:30 to 6:00 pm
2001 McGill College Ave. Room 606

Catégories: Global Health Feed

Scaringi Lecture Series in Speech Language Pathology - Research Talk

McGill Faculty of Medicine news - lun, 03/17/2025 - 14:53

Research Talk
Thursday April 3, 2025, 4:30 to 6:00 pm
2001 McGill College Ave. Room 606

Catégories: Global Health Feed

Scaringi Lecture Series in Speech Language Pathology - Research Talk

McGill Faculty of Medicine news - lun, 03/17/2025 - 14:53

Research Talk
Thursday April 3, 2025, 4:30 to 6:00 pm
2001 McGill College Ave. Room 606

Catégories: Global Health Feed

Scaringi Lecture Series in Speech Language Pathology - Research Talk

McGill Faculty of Medicine news - lun, 03/17/2025 - 14:53

Research Talk
Thursday April 3, 2025, 4:30 to 6:00 pm
2001 McGill College Ave. Room 606

Catégories: Global Health Feed

Scaringi Lecture Series in Speech Language Pathology - Research Talk

McGill Faculty of Medicine news - lun, 03/17/2025 - 14:53

Research Talk
Thursday April 3, 2025, 4:30 to 6:00 pm
2001 McGill College Ave. Room 606

Catégories: Global Health Feed

Project to create AI model for ALS receives Génome Québec funding

McGill Faculty of Medicine news - lun, 03/17/2025 - 11:29
$400,000 will fuel public-private collaboration to discover new disease biomarkers

 

A new project co-led by Thomas Durcan, PhD, Director of The Neuro's Early Drug Discovery Unit, and overseen by Mathilde Chaineau, PhD, the EDDU’s program manager, will receive $400,000 in support from Génome Québec. In partnership with Nardin Nakhla and Armstrong Murira from the Montreal-based company Simmunome, Durcan and Chaineau will develop a computational model of amyotrophic lateral sclerosis (ALS) on which to test for new biomarkers and therapeutic targets.

Catégories: Global Health Feed

Project to create AI model for ALS receives Génome Québec funding

McGill Faculty of Medicine news - lun, 03/17/2025 - 11:29
$400,000 will fuel public-private collaboration to discover new disease biomarkers

 

A new project co-led by Thomas Durcan, PhD, Director of The Neuro's Early Drug Discovery Unit, and overseen by Mathilde Chaineau, PhD, the EDDU’s program manager, will receive $400,000 in support from Génome Québec. In partnership with Nardin Nakhla and Armstrong Murira from the Montreal-based company Simmunome, Durcan and Chaineau will develop a computational model of amyotrophic lateral sclerosis (ALS) on which to test for new biomarkers and therapeutic targets.

Catégories: Global Health Feed

Project to create AI model for ALS receives Génome Québec funding

McGill Faculty of Medicine news - lun, 03/17/2025 - 11:29
$400,000 will fuel public-private collaboration to discover new disease biomarkers

 

A new project co-led by Thomas Durcan, PhD, Director of The Neuro's Early Drug Discovery Unit, and overseen by Mathilde Chaineau, PhD, the EDDU’s program manager, will receive $400,000 in support from Génome Québec. In partnership with Nardin Nakhla and Armstrong Murira from the Montreal-based company Simmunome, Durcan and Chaineau will develop a computational model of amyotrophic lateral sclerosis (ALS) on which to test for new biomarkers and therapeutic targets.

Catégories: Global Health Feed

Project to create AI model for ALS receives Génome Québec funding

McGill Faculty of Medicine news - lun, 03/17/2025 - 11:29
$400,000 will fuel public-private collaboration to discover new disease biomarkers

 

A new project co-led by Thomas Durcan, PhD, Director of The Neuro's Early Drug Discovery Unit, and overseen by Mathilde Chaineau, PhD, the EDDU’s program manager, will receive $400,000 in support from Génome Québec. In partnership with Nardin Nakhla and Armstrong Murira from the Montreal-based company Simmunome, Durcan and Chaineau will develop a computational model of amyotrophic lateral sclerosis (ALS) on which to test for new biomarkers and therapeutic targets.

Catégories: Global Health Feed

Project to create AI model for ALS receives Génome Québec funding

McGill Faculty of Medicine news - lun, 03/17/2025 - 11:29
$400,000 will fuel public-private collaboration to discover new disease biomarkers

 

A new project co-led by Thomas Durcan, PhD, Director of The Neuro's Early Drug Discovery Unit, and overseen by Mathilde Chaineau, PhD, the EDDU’s program manager, will receive $400,000 in support from Génome Québec. In partnership with Nardin Nakhla and Armstrong Murira from the Montreal-based company Simmunome, Durcan and Chaineau will develop a computational model of amyotrophic lateral sclerosis (ALS) on which to test for new biomarkers and therapeutic targets.

Catégories: Global Health Feed

Project to create AI model for ALS receives Génome Québec funding

McGill Faculty of Medicine news - lun, 03/17/2025 - 11:29
$400,000 will fuel public-private collaboration to discover new disease biomarkers

 

A new project co-led by Thomas Durcan, PhD, Director of The Neuro's Early Drug Discovery Unit, and overseen by Mathilde Chaineau, PhD, the EDDU’s program manager, will receive $400,000 in support from Génome Québec. In partnership with Nardin Nakhla and Armstrong Murira from the Montreal-based company Simmunome, Durcan and Chaineau will develop a computational model of amyotrophic lateral sclerosis (ALS) on which to test for new biomarkers and therapeutic targets.

Catégories: Global Health Feed

Pages

    McGill GHP Logo (McGill crest separated by a vertical bar from a purple globe and a partial arc with "McGill Global health Programs" in English & French)

McGill University is located on land which has long served as a site of meeting and exchange amongst Indigenous Peoples, including the Haudenosaunee and Anishinabeg Nations. McGill honours, recognizes, and respects these nations as the traditional stewards of the lands and waters on which peoples of the world now gather. Today, this meeting place is still the home to many Indigenous Peoples from across Turtle Island. We are grateful to have the opportunity to work on this land.

Learn more about Indigenous Initiatives at McGill.

Back to top